EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?

Mangala Hegde, Sosmitha Girisa, Bandari BharathwajChetty, Ravichandran Vishwa iD, Ajaikumar B Kunnumakkara iD

ACS Omega · 28.03.2023 · 8 (12) · 10713-10746

DOI: 10.1021/acsomega.2c07326 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Omega, online erschienen am 13.03.2023. Verfasst von Mangala Hegde und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India. Die Arbeit wurde bisher 316-mal zitiert (Crossref) und nennt 314 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Engineering Research Board, Department of Biotechnology , Ministry of Science and Technology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India.

ORCID-Profile: Ravichandran Vishwa, Ajaikumar B Kunnumakkara

Förderung

  • Science and Engineering Research Board
  • Department of Biotechnology , Ministry of Science and Technology

Zitieren

APA

Hegde, M., Girisa, S., BharathwajChetty, B., Vishwa, R., & Kunnumakkara, A. B. (2023). Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?. ACS Omega, 8(12), 10713-10746. https://doi.org/10.1021/acsomega.2c07326

Vancouver

Hegde M, Girisa S, BharathwajChetty B, Vishwa R, Kunnumakkara AB. Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?. ACS Omega. 2023;8(12):10713-10746. doi:10.1021/acsomega.2c07326

BibTeX
@article{Hegde2023,
  author = {Hegde, Mangala and Girisa, Sosmitha and BharathwajChetty, Bandari and Vishwa, Ravichandran and Kunnumakkara, Ajaikumar B},
  title = {Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?},
  journal = {ACS Omega},
  year = {2023},
  volume = {8},
  number = {12},
  pages = {10713--10746},
  doi = {10.1021/acsomega.2c07326}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche